103 related articles for article (PubMed ID: 11448219)
1. Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents.
Giannessi F; Chiodi P; Marzi M; Minetti P; Pessotto P; De Angelis F; Tassoni E; Conti R; Giorgi F; Mabilia M; Dell'Uomo N; Muck S; Tinti MO; Carminati P; Arduini A
J Med Chem; 2001 Jul; 44(15):2383-6. PubMed ID: 11448219
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
Giannessi F; Pessotto P; Tassoni E; Chiodi P; Conti R; De Angelis F; Dell'Uomo N; Catini R; Deias R; Tinti MO; Carminati P; Arduini A
J Med Chem; 2003 Jan; 46(2):303-9. PubMed ID: 12519067
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of R-aminocarnitine without ammonium moiety as liver carnitine palmitoyltransferase I (L-CPT I) inhibitors.
Tassoni E; Conti R; Gallo G; Vincenti S; Mastrofrancesco L; Brunetti T; Cabri W; Giannessi F
ChemMedChem; 2011 Nov; 6(11):1977-80. PubMed ID: 21834096
[No Abstract] [Full Text] [Related]
4. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
Brady PS; Brady LJ
Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
[TBL] [Abstract][Full Text] [Related]
5. Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
Tassoni E; Conti R; Gallo G; Vincenti S; Dell'Uomo N; Mastrofrancesco L; Ricciolini R; Cabri W; Carminati P; Giannessi F
ChemMedChem; 2010 May; 5(5):666-9. PubMed ID: 20232438
[No Abstract] [Full Text] [Related]
6. Stereoisomeric acylamidomorpholinium carnitine analogues: selective inhibitors of carnitine palmitoyltransferase I and II.
Savle PS; Pande SV; Lee TS; Gandour RD
Bioorg Med Chem Lett; 1999 Nov; 9(21):3099-102. PubMed ID: 10560732
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors.
Anderson RC; Balestra M; Bell PA; Deems RO; Fillers WS; Foley JE; Fraser JD; Mann WR; Rudin M; Villhauer EB
J Med Chem; 1995 Sep; 38(18):3448-50. PubMed ID: 7658430
[No Abstract] [Full Text] [Related]
8. Inhibition of mitochondrial carnitine palmitoyltransferase-1 by a trimetazidine derivative, S-15176.
Hamdan M; Urien S; Le Louet H; Tillement JP; Morin D
Pharmacol Res; 2001 Aug; 44(2):99-104. PubMed ID: 11516258
[TBL] [Abstract][Full Text] [Related]
9. Pig liver carnitine palmitoyltransferase I, with low Km for carnitine and high sensitivity to malonyl-CoA inhibition, is a natural chimera of rat liver and muscle enzymes.
Nicot C; Hegardt FG; Woldegiorgis G; Haro D; Marrero PF
Biochemistry; 2001 Feb; 40(7):2260-6. PubMed ID: 11329295
[TBL] [Abstract][Full Text] [Related]
10. Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme.
Relat J; Nicot C; Gacias M; Woldegiorgis G; Marrero PF; Haro D
Biochemistry; 2004 Oct; 43(39):12686-91. PubMed ID: 15449958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of (+)- and (-)-hemipalmitoylcarnitinium as inhibitors of hepatic mitochondrial carnitine palmitoyltransferases in diabetic rats.
Savle PS; Neptune NE; Yang Y; Rouden JH; Kite BL; Sugandhi EW; Macri RV; Kashfi K; Gandour RD
Med Chem; 2005 Sep; 1(5):445-53. PubMed ID: 16787328
[TBL] [Abstract][Full Text] [Related]
12. Carnitine analogues and carnitine palmitoyltransferases.
Murthy MS; Ramsay RR; Pande SV
Biochem Soc Trans; 1990 Aug; 18(4):604-5. PubMed ID: 2276460
[No Abstract] [Full Text] [Related]
13. Effects of C-methylated carnitine analogs on rates of mitochondrial fatty acid oxidation.
Brouillette WJ; Puckett SW; Comber RN; Hosmer CA
Biochem Pharmacol; 1993 Nov; 46(9):1671-3. PubMed ID: 8240425
[TBL] [Abstract][Full Text] [Related]
14. (+)-Hemipalmitoylcarnitinium strongly inhibits carnitine palmitoyltransferase-I in intact mitochondria.
Gandour RD; Leung OT; Greway AT; Ramsay RR; Nic a'Bháird N; Fronczek FR; Bellard BM; Kumaravel G
J Med Chem; 1993 Jan; 36(2):237-42. PubMed ID: 8423595
[TBL] [Abstract][Full Text] [Related]
15. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
[TBL] [Abstract][Full Text] [Related]
16. Binding of malonyl-CoA to isolated mitochondria. Evidence for high- and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity.
Bird MI; Saggerson ED
Biochem J; 1984 Sep; 222(3):639-47. PubMed ID: 6487267
[TBL] [Abstract][Full Text] [Related]
17. Expression and possible role of muscle-type carnitine palmitoyltransferase I during sperm development in the rat.
Adams SH; Esser V; Brown NF; Ing NH; Johnson L; Foster DW; McGarry JD
Biol Reprod; 1998 Dec; 59(6):1399-405. PubMed ID: 9828184
[TBL] [Abstract][Full Text] [Related]
18. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
Brady LJ; Brady PS; Gandour RD
Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatic carnitine palmitoyltransferase. Use of bromoacyl derivatives and antibodies.
Brady PS; Dunker AK; Brady LJ
Biochem J; 1987 Feb; 241(3):751-7. PubMed ID: 3593221
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of purified, active and malonyl-CoA-sensitive rat liver carnitine palmitoyltransferase I: relationship between membrane environment and malonyl-CoA sensitivity.
McGarry JD; Brown NF
Biochem J; 2000 Jul; 349(Pt 1):179-87. PubMed ID: 10861226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
